Fri, October 12, 2012
[ Fri, Oct 12th 2012 ] - Market Wire
Abbott Awards Two Scholarships to Inspirational Students Living with Cystic Fibrosis
[ Fri, Oct 12th 2012 ] - Market Wire
Aeterna Zentaris Announces Pricing of US$16.5 Mil .. ion Public Offering of Common Shares and Warrants
[ Fri, Oct 12th 2012 ] - Market Wire
Arena Pharmaceuticals Initiates Phase 1 Multiple .. ial of APD811 for Pulmonary Arterial Hypertension
[ Fri, Oct 12th 2012 ] - Market Wire
Mesa Labs Reports Transition of its CFO Position
[ Fri, Oct 12th 2012 ] - Market Wire
NuPathe Granted Financial Viability Exception by NASDAQ
[ Fri, Oct 12th 2012 ] - Market Wire
Accuray Incorporated CEO Resigns, Board Appoints Successor for Next Phase of Growth
[ Fri, Oct 12th 2012 ] - Market Wire
Lexicon Initiates Phase 3 Clinical Trial Of Telot .. stat Etiprate In Patients With Carcinoid Syndrome
[ Fri, Oct 12th 2012 ] - Market Wire
Second Phase 2 Trial Of Telotristat Etiprate Shows Positive Results In Carcinoid Syndrome
[ Fri, Oct 12th 2012 ] - Market Wire
Simcere Pharmaceutical Group Announces Resignation of an Independent Director
Thu, October 11, 2012
[ Thu, Oct 11th 2012 ] - Market Wire
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants
[ Thu, Oct 11th 2012 ] - Market Wire
Solta Medical to Report Third Quarter 2012 Result .. ease and Host Conference Call on October 30, 2012
[ Thu, Oct 11th 2012 ] - Market Wire
Cytomedix Announces Presentation of ALD-401 Safety Data at the World Stroke Congress in Brazil
[ Thu, Oct 11th 2012 ] - Market Wire
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
[ Thu, Oct 11th 2012 ] - Market Wire
Merit Medical Systems Announces Earnings Release .. Information For The Third Quarter Ended Septembe
[ Thu, Oct 11th 2012 ] - Market Wire
Sirona Biochem Names Neil Belenkie as Chief Executive Officer
[ Thu, Oct 11th 2012 ] - Market Wire
Amerigroup Foundation Presents 'Champion for Children' Award to Texas Sen. Juan Hinojosa
[ Thu, Oct 11th 2012 ] - Market Wire
CryoLife Announces Release Date and Teleconferenc .. Details for 2012 Third Quarter Financial Results
[ Thu, Oct 11th 2012 ] - Market Wire
Isis Investment In Regulus Valued At $28 Million At Completion Of Regulus Initial Public Offering
[ Thu, Oct 11th 2012 ] - Market Wire
QUMAS Compliance Platform Chosen by Emergent BioS .. lutions to Manage Quality Across the Organization
[ Thu, Oct 11th 2012 ] - Market Wire
Bioheart Presents at AABB Conference in Boston
[ Thu, Oct 11th 2012 ] - Market Wire
Implant Sciences Continues Sales Into Africa for Corporate Security
[ Thu, Oct 11th 2012 ] - Market Wire
Sequenom Announces Appointment Of Bill Bowen To Senior Vice President And General Counsel
[ Thu, Oct 11th 2012 ] - Market Wire
Marina Biotech, Inc. Announces Full Year 2011 Financial Results
[ Thu, Oct 11th 2012 ] - Market Wire
Dynamic Energy Alliance Subsidiary Announces Agre .. Exclusive Worldwide License for High Value Organ
[ Thu, Oct 11th 2012 ] - Market Wire
Lilly's Fifth Global Day Of Service Focuses On Local Waterways
Wed, October 10, 2012
[ Wed, Oct 10th 2012 ] - Market Wire
MSA Schedules Third Quarter Earnings Webcast
[ Wed, Oct 10th 2012 ] - Market Wire
Universal Health Services, Inc. Completes Acquisi .. tion And Divestiture Of Auburn Regional Medical C
[ Wed, Oct 10th 2012 ] - Market Wire
CNS honored guest lecturer Dr. Ralph Dacey speaks on impact of iMRI on Oct. 10
[ Wed, Oct 10th 2012 ] - Market Wire
Levi &;; Korsinsky Notifies Investors W .. t in Questcor Pharmaceuticals, Inc. of Class Acti
[ Wed, Oct 10th 2012 ] - Market Wire
IDEXX Laboratories to Release 2012 Third Quarter Financial Results
[ Wed, Oct 10th 2012 ] - Market Wire
MiMedx Group, Inc. Announces Release Date for 2012 Third Quarter Results
[ Wed, Oct 10th 2012 ] - Market Wire
Regeneron to Report Third Quarter 2012 Financial .. t Conference Call and Webcast on October 24, 2012
[ Wed, Oct 10th 2012 ] - Market Wire
Edwards Lifesciences Acquires BMEYE
[ Wed, Oct 10th 2012 ] - Market Wire
BD Announces Chief Financial Officer Transition
[ Wed, Oct 10th 2012 ] - Market Wire
Theratechnologies Provides Follow-Up Regulatory Update on Tesamorelin
[ Wed, Oct 10th 2012 ] - Market Wire
MethylGene Provides Clinical Update on its MGCD290 Novel Antifungal Therapeutic Program
[ Wed, Oct 10th 2012 ] - Market Wire
First Patient Enrolled in REPRISE II TAVR Clinica .. afety and Performance of the Lotusa" Valve System
Tue, October 9, 2012
[ Tue, Oct 09th 2012 ] - Market Wire
Paladin Announces Agreement With QRxPharma for Novel Acute Pain Product
[ Tue, Oct 09th 2012 ] - Market Wire
Quidel to Hold Third Quarter 2012 Financial Results Conference Call on October 23, 2012
[ Tue, Oct 09th 2012 ] - Market Wire
Depomed, Inc. Appoints Dr. Samuel Saks To Its Board Of Directors
[ Tue, Oct 09th 2012 ] - Market Wire
PDL BioPharma Completes Royalty Transaction with AxoGen
[ Tue, Oct 09th 2012 ] - Market Wire
Amerigroup Announces Conference Participation for October
[ Tue, Oct 09th 2012 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Orapred ODT
[ Tue, Oct 09th 2012 ] - Market Wire
Manhattan Isotope Technology Receives Drug Master File Acknowledgment Letter From FDA
[ Tue, Oct 09th 2012 ] - Market Wire
Extendicare Announces 2012 Third Quarter Financia .. ults News Release and Conference Call Information
[ Tue, Oct 09th 2012 ] - Market Wire
Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101
[ Tue, Oct 09th 2012 ] - Market Wire
Cynosure To Host Third-Quarter 2012 Financial Results Conference Call On October 23
[ Tue, Oct 09th 2012 ] - Market Wire
Aethlon Medical to Present at the RedChip 15th Annual Small-Cap Conference on October 11th
[ Tue, Oct 09th 2012 ] - Market Wire
Boston Scientific Launches Victory Guidewire For Crossing Resistant Lesions In Peripheral Arteries
[ Tue, Oct 09th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Achieves Important Milestone for AML Program
[ Tue, Oct 09th 2012 ] - Market Wire
Immunovaccine Reports Positive Interim Results fr .. of Ovarian Cancer Vaccine Candidate, DPX-Survivac
[ Tue, Oct 09th 2012 ] - Market Wire
Matrixx Initiatives Revises All-cash Acquisition Offer For ProPhase Labs
Mon, October 8, 2012
[ Mon, Oct 08th 2012 ] - Market Wire
Boston Scientific to Acquire Rhythmia Medical, Inc.
[ Mon, Oct 08th 2012 ] - Market Wire
Edwards Lifesciences Announces Preliminary Third Quarter 2012 Sales
[ Mon, Oct 08th 2012 ] - Market Wire
Boston Scientific To Announce Third-Quarter 2012 Financial Results On October 18th
[ Mon, Oct 08th 2012 ] - Market Wire
Targacept Takes Further Actions to Align Resources with Corporate Objectives
[ Mon, Oct 08th 2012 ] - Market Wire
Dr. Reddy's Custom Pharmaceutical Services (CPS) .. ands Its Manufacturing Operations in Mirfield, UK
[ Mon, Oct 08th 2012 ] - Market Wire
Optimer Pharmaceuticals to Sell Remaining Ownersh .. Optimer Biotechnology, Inc. for U.S. $60 Million
[ Mon, Oct 08th 2012 ] - Market Wire
Revance Therapeutics Regains All Worldwide Rights to Its Botulinum Toxin Products
[ Mon, Oct 08th 2012 ] - Market Wire
AMILPAR - Associao Entre Amil e UnitedHealth Group
[ Mon, Oct 08th 2012 ] - Market Wire
AMILPAR - Association With UnitedHealth Group
[ Mon, Oct 08th 2012 ] - Market Wire
Lieff Cabraser Reminds Assisted Living Concepts, .. tors of Upcoming Deadline in Class Action Lawsuit
[ Mon, Oct 08th 2012 ] - Market Wire
Express Scripts Joins Qsymiaa" (Phentermine And T .. Release) Certified Home Delivery Pharmacy Network
[ Mon, Oct 08th 2012 ] - Market Wire
GTx to Present Scientific Poster Presentations on .. event and Treat Muscle Wasting in Cancer Patients
[ Mon, Oct 08th 2012 ] - Market Wire
NuPathe to Present at the Safeguard Scientifics Investor Day 2012
[ Mon, Oct 08th 2012 ] - Market Wire
UnitedHealth Group, Amil to Combine
[ Mon, Oct 08th 2012 ] - Market Wire
EXPAREL®; as the Foundation of a Multimoda .. l Significance in All Primary Endpoints, Includin
[ Mon, Oct 08th 2012 ] - Market Wire
Wright Medical Group, Inc. Announces Expiration of Deferred Prosecution Agreement
Sun, October 7, 2012
[ Sun, Oct 07th 2012 ] - Market Wire
Groundbreaking study shows that a simple, rapid P .. stratify pregnant women with suspected pre-eclamp
[ Sun, Oct 07th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 Investing In Questcor Pharmaceuticals, Inc.
Sat, October 6, 2012
[ Sat, Oct 06th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. sting In Peregrine Pharmaceuticals, Inc. To Conta
[ Sat, Oct 06th 2012 ] - Market Wire
Rosen Law Firm Announces Investigation of China N .. Connection With Going Private Proposal from Kingb
[ Sat, Oct 06th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. Losses Investing In Peregrine Pharmaceuticals, In
[ Sat, Oct 06th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. cess of $100,000 Investing In Questcor Pharmaceut
Fri, October 5, 2012
[ Fri, Oct 05th 2012 ] - Market Wire
Watson Receives Approval from European Commission for Pending Actavis Acquisition
[ Fri, Oct 05th 2012 ] - Market Wire
Milberg LLP Announces Pendency of Class Action La .. e Pharmaceuticals, Inc. (PPHM) -- PeregrineLawsui
[ Fri, Oct 05th 2012 ] - Market Wire
Alliance HealthCare Services to Present at the De .. che Bank 20th Annual Leveraged Finance Conference
[ Fri, Oct 05th 2012 ] - Market Wire
Covance Inc. Invites You to Join the Webcast of I .. rd Quarter 2012 Financial Results Conference Call
[ Fri, Oct 05th 2012 ] - Market Wire
Fresenius Medical Care Recommends Seasonal Flu Shots for Dialysis Patients
[ Fri, Oct 05th 2012 ] - Market Wire
Hospira to Host Conference Call for Third-quarter 2012 Results
[ Fri, Oct 05th 2012 ] - Market Wire
Humana Bringing 200 New Jobs to Greater Cincinnati
[ Fri, Oct 05th 2012 ] - Market Wire
Rosen Law Firm Announces Investigation of Shengta .. n With Going Private Proposal from its Chairman a
[ Fri, Oct 05th 2012 ] - Market Wire
Ohr Pharmaceutical to Present at the 11th Annual BIO Investor Forum
[ Fri, Oct 05th 2012 ] - Market Wire
Amerigroup Foundation Presents 'Champion for Children' Award to Texas Representative John Zerwas
[ Fri, Oct 05th 2012 ] - Market Wire
Multiple miRNA Markers Associated with Angiogenes .. pair Expressed in Cytori’s Cell Therapy
[ Fri, Oct 05th 2012 ] - Market Wire
Cubist Announces Management Change
[ Fri, Oct 05th 2012 ] - Market Wire
Equity Research on HCA Holdings Inc. and Communit .. Healthcare Hospitals Taking the Good With the Bad
[ Fri, Oct 05th 2012 ] - Market Wire
The Law Firm of Wohl & Fruchter LLP Announces Investigation of Amyris, Inc.
[ Fri, Oct 05th 2012 ] - Market Wire
MannKind Completes Patient Recruitment in Two Phase 3 Clinical Studies of AFREZZA
[ Fri, Oct 05th 2012 ] - Market Wire
Boston Scientific ottiene l'approvazione della FD .. S-ICD pensato per i pazienti a rischio di arresto
Thu, October 4, 2012
[ Thu, Oct 04th 2012 ] - Market Wire
BARDA Exercises Contract Option as Emergent BioSo .. icant Progress in rPA Anthrax Vaccine Development
[ Thu, Oct 04th 2012 ] - Market Wire
Humana Awarded Contract to Manage Comprehensive M .. id Coverage for Residents in 16 Kentucky Counties
[ Thu, Oct 04th 2012 ] - Market Wire
Informational Seminars Set To Help Kentucky Retir .. Members Get Most From New Medicare Advantage Plan
[ Thu, Oct 04th 2012 ] - Market Wire
Sirona Biochem to Present Scientific Poster at Canadian Diabetes Professional Conference
[ Thu, Oct 04th 2012 ] - Market Wire
XTL Biopharmaceuticals Effectuates ADR Ratio Change
[ Thu, Oct 04th 2012 ] - Market Wire
Bio-Path Holdings Adds New Board Member
[ Thu, Oct 04th 2012 ] - Market Wire
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology
[ Thu, Oct 04th 2012 ] - Market Wire
Volcano annonce l'obtention du marquage CE et de .. de son nouveau cathter digital IVUS Visions PV .
[ Thu, Oct 04th 2012 ] - Market Wire
ERBA Diagnostics, Inc. Acquires Escalon Medical Corp. Clinical Diagnostics Business
[ Thu, Oct 04th 2012 ] - Market Wire
Durata Therapeutics Presenting Two Abstracts Concerning Dalbavancin at IDWeek 2012
[ Thu, Oct 04th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation and Webcast at 11th Annual BIO Investor Forum
[ Thu, Oct 04th 2012 ] - Market Wire
Milestone Scientific Signs on Dental American Group
[ Thu, Oct 04th 2012 ] - Market Wire
Boston Therapeutics Wins FDA Approval to File an .. rug Application for PAZAMET(TM) to Treat Diabetes
[ Thu, Oct 04th 2012 ] - Market Wire
BioClinica, Inc. to Participate in Upcoming Indus .. obal Technology–Enhanced Clinical Trial
[ Thu, Oct 04th 2012 ] - Market Wire
New Caregiver Robots Poised to Change Elderly Lives
[ Thu, Oct 04th 2012 ] - Market Wire
Syneron destaca sus nuevos productos en la IMCAS Asia Meeting
Wed, October 3, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
Law Offices of Howard G. Smith Announces Class Ac .. on Lawsuit Against Questcor Pharmaceuticals, Inc.
[ Wed, Oct 03rd 2012 ] - Market Wire
Florida Blue Partners with Healthways to Offer Si .. neakers®;; Fitness Program Through 2015
[ Wed, Oct 03rd 2012 ] - Market Wire
Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
Electrochem Offers Expanded Total Power Solutions; Retires Micro Power Brand
[ Wed, Oct 03rd 2012 ] - Market Wire
Antares Pharma Announces Pricing of Public Offering of Common Stock
[ Wed, Oct 03rd 2012 ] - Market Wire
Lpath Begins iSONEP Dosing in Nexus Phase 2 Study
[ Wed, Oct 03rd 2012 ] - Market Wire
Verastem to Present at BIO Investor Forum and Participate in Cancer Stem Cell Panel
[ Wed, Oct 03rd 2012 ] - Market Wire
Durata Therapeutics to Present at 11th Annual BIO Investor Forum
[ Wed, Oct 03rd 2012 ] - Market Wire
AcelRx Receives Notice of Eligibility for Central .. icines Agency for the Sufentanil NanoTab PCA Syst
[ Wed, Oct 03rd 2012 ] - Market Wire
Aeterna Zentaris Announces Share Consolidation to Regain NASDAQ Compliance
[ Wed, Oct 03rd 2012 ] - Market Wire
Market Influences That Drive Equities Forward - I .. rt on Abbott Laboratories and Glaxosmithkline Plc
[ Wed, Oct 03rd 2012 ] - Market Wire
Sarepta Therapeutics Receives Notice From Departm .. ense for Termination of Ebola Therapeutic Program
[ Wed, Oct 03rd 2012 ] - Market Wire
Sarepta Therapeutics Announces Eteplirsen Meets P .. Novel Dystrophin and Achieves Significant Clinica
[ Wed, Oct 03rd 2012 ] - Market Wire
Lorus Therapeutics to Present at BioContact 2012 in Quebec City
[ Wed, Oct 03rd 2012 ] - Market Wire
Health Management to Present at the Deutsche Bank 20th Annual Leveraged Finance Conference
[ Wed, Oct 03rd 2012 ] - Market Wire
St. Jude Medical's Peripheral Nerve Stimulation S .. dy Confirms Benefit for Chronic Migraine Patients
Tue, October 2, 2012
[ Tue, Oct 02nd 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Peregrine Pharmaceuticals, Inc.
[ Tue, Oct 02nd 2012 ] - Market Wire
GreeneStone Supports the Cause of Mental Health with Charitable Foundation
[ Tue, Oct 02nd 2012 ] - Market Wire
Aeterna Zentaris Presented Poster on Oral Prostat .. 120, at International Urology Conference in Japan
[ Tue, Oct 02nd 2012 ] - Market Wire
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum
[ Tue, Oct 02nd 2012 ] - Market Wire
NewLink to Present at 3rd Annual Cancer Immunotherapy Conference
[ Tue, Oct 02nd 2012 ] - Market Wire
LCA-Vision Reports Third Quarter 2012 Procedure Volume
[ Tue, Oct 02nd 2012 ] - Market Wire
Antares Pharma Receives Development Milestone Payment
[ Tue, Oct 02nd 2012 ] - Market Wire
Biostar Pharmaceuticals, Inc. To Manufacture And .. ply Xijing Military Hospital With Three New Drugs
[ Tue, Oct 02nd 2012 ] - Market Wire
DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule
[ Tue, Oct 02nd 2012 ] - Market Wire
Studies assess linagliptin treatment in adults wi .. (T2D), as well as add-on to basal insulin therapy
[ Tue, Oct 02nd 2012 ] - Market Wire
Lilly and Boehringer Ingelheim Present Health Out .. for Investigational Novel Basal Insulin Analogue
[ Tue, Oct 02nd 2012 ] - Market Wire
OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference
[ Tue, Oct 02nd 2012 ] - Market Wire
Life Technologies establece un nuevo estndar mundial con el kit GlobalFilera" Express
[ Tue, Oct 02nd 2012 ] - Market Wire
Department of Justice Drops DaVita Inquiry
[ Tue, Oct 02nd 2012 ] - Market Wire
NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction
[ Tue, Oct 02nd 2012 ] - Market Wire
Medicure Announces Intention to Seek Expanded Aggrastat Label
Mon, October 1, 2012
[ Mon, Oct 01st 2012 ] - Market Wire
HealthSpring Unveils 2013 Medicare Advantage Plans with More Choices
[ Mon, Oct 01st 2012 ] - Market Wire
Luminex Corporation Participates in Community Initiatives to Save Lives
[ Mon, Oct 01st 2012 ] - Market Wire
Tenet Announces Four-Point Plan to Drive Shareholder Value Creation
[ Mon, Oct 01st 2012 ] - Market Wire
Extendicare Announces Exercise of Over-Allotment .. Closes on Lease of Remaining Two Kentucky Centers
[ Mon, Oct 01st 2012 ] - Market Wire
Care Improvement Plus Unveils 2013 Medicare Advantage Plans
[ Mon, Oct 01st 2012 ] - Market Wire
Horizon Pharma Announces Completion of Sales Force Expansion
[ Mon, Oct 01st 2012 ] - Market Wire
Implant Sciences Ships Explosives Trace Detectors .. to Protect Petroleum Infrastructure and Transport
[ Mon, Oct 01st 2012 ] - Market Wire
MethylGene Presents Clinical Data on MGCD265 at t .. Society for Medical Oncology (ESMO) 2012 Congress
[ Mon, Oct 01st 2012 ] - Market Wire
FONAR Reports Record Profits From Operations for .. me Doubles From Fiscal 2011;; Revenues Inc
[ Mon, Oct 01st 2012 ] - Market Wire
Bovie Medical to present at the 2012 SeeThruEquit .. p and Microcap Conference on Tuesday, October 2nd
[ Mon, Oct 01st 2012 ] - Market Wire
AVEO and Astellas Announce New Data Presented at .. ing the Safety and Tolerability Profile of Tivoza
[ Mon, Oct 01st 2012 ] - Market Wire
GTx Announces Sale of Fareston®;
[ Mon, Oct 01st 2012 ] - Market Wire
Syneron's elurea" Kicks Off the Break Up. Get Even! Campaign
[ Mon, Oct 01st 2012 ] - Market Wire
Sunshine Heart Announces Conditional Approval of .. E From the FDA for C-Pulse(R) Heart Assist System
[ Mon, Oct 01st 2012 ] - Market Wire
Millennium and Seattle Genetics Highlight Data fr .. imab Vedotin) Trial in Patients with Newly Diagno
[ Mon, Oct 01st 2012 ] - Market Wire
Could Stem Cells Hold the Key to Treating Traumatic Brain Injuries?
Sun, September 30, 2012
[ Sun, Sep 30th 2012 ] - Market Wire
Genomic Health anuncia la presentacin de tres estudios Oncotype DX sobre cncer de mama y colon
[ Sun, Sep 30th 2012 ] - Market Wire
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
[ Sun, Sep 30th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Preliminary D .. H-302 in Combination With Bevacizumab in Patients
[ Sun, Sep 30th 2012 ] - Market Wire
Interim Data for Cabozantinib 40 mg Dose Cohort i .. tant Prostate Cancer Presented at ESMO 2012 Congr
[ Sun, Sep 30th 2012 ] - Market Wire
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Sat, September 29, 2012
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. tment-Naï;ve and Previously-Treated Metas
[ Sat, Sep 29th 2012 ] - Market Wire
Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. Treatment-Naï;;ve and Previously-Treat
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. in Treatment-Naï;;;ve and Previous
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. umab) in Treatment-Naï;;;;ve and
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. limumab) in Treatment-Naï;;;;;
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. (ipilimumab) in Treatment-Naï;;;;
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. 59; (ipilimumab) in Treatment-Naï;;;
[ Sat, Sep 29th 2012 ] - Market Wire
ARIAD Presents Initial Clinical Proof-of-Concept .. Non-Small Cell Lung Cancer at ESMO 2012 Congress
[ Sat, Sep 29th 2012 ] - Market Wire
Updated Results from Phase 2b/3 GALAXY Trial Show .. vival from the Addition of Ganetespib to Docetaxe
[ Sat, Sep 29th 2012 ] - Market Wire
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Fri, September 28, 2012
[ Fri, Sep 28th 2012 ] - Market Wire
Dehaier Medical Signed an Exclusive Distribution .. GCE Group, Europe's Leading Gas-equipment Company
[ Fri, Sep 28th 2012 ] - Market Wire
Biotech Industry Look to Benefit From the Introdu .. Technology Small Business Research Incentives Act
[ Fri, Sep 28th 2012 ] - Market Wire
Dynatronics Announces Fourth Quarter and Year-End Results
[ Fri, Sep 28th 2012 ] - Market Wire
Idera Pharmaceuticals to Present at the 3rd Annual Cancer Immunotherapy Conference
[ Fri, Sep 28th 2012 ] - Market Wire
Cytomedix Announces Poster Presentation at Britis .. thetic Plastic Surgeons Annual Scientific Meeting
[ Fri, Sep 28th 2012 ] - Market Wire
A.P. Pharma Resubmits New Drug Application for AP .. the Prevention of Chemotherapy-Induced Nausea an
[ Fri, Sep 28th 2012 ] - Market Wire
Where We Are Headed - New Outlook on Alere Inc. and PerkinElmer, Inc.
[ Fri, Sep 28th 2012 ] - Market Wire
AVEO and Astellas Announce Submission of New Drug .. or the Treatment of Advanced Renal Cell Carcinoma
[ Fri, Sep 28th 2012 ] - Market Wire
Shareholder Rights Law Firm Johnson & Weaver, LLP .. uestcor Pharmaceuticals Inc. for Securities Fraud
[ Fri, Sep 28th 2012 ] - Market Wire
Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review
[ Fri, Sep 28th 2012 ] - Market Wire
Oncolytics Biotech Inc. Announces the Appointment of Dr. Alan J. Tuchman as Chief Medical Officer
[ Fri, Sep 28th 2012 ] - Market Wire
call for signatures
[ Fri, Sep 28th 2012 ] - Market Wire
EYLEA (aflibercept) Injection Approved for the Tr .. of Wet Age-Related Macular Degeneration in Japan
[ Fri, Sep 28th 2012 ] - Market Wire
Boston Scientific Launches Vercisea" Deep Brain Stimulation System in Europe
[ Fri, Sep 28th 2012 ] - Market Wire
Unprecedented progression-free survival benefit w .. clinically meaningful improvements in life-limit
Thu, September 27, 2012
[ Thu, Sep 27th 2012 ] - Market Wire
30 a.m. Eastern
[ Thu, Sep 27th 2012 ] - Market Wire
Baxter Appoints Two New Directors to Its Board
[ Thu, Sep 27th 2012 ] - Market Wire
Dynamic Energy Alliance to Present at Undiscovered Equities' New York Conference
[ Thu, Sep 27th 2012 ] - Market Wire
Teva Expands Central Nervous System (CNS) Develop .. n of Huntexil®; Development Program Rights
[ Thu, Sep 27th 2012 ] - Market Wire
Watson Announces Offering of Senior Unsecured Notes
[ Thu, Sep 27th 2012 ] - Market Wire
Boston Scientific Launches Emergea" PTCA Balloon Dilatation Catheter in the U.S.
[ Thu, Sep 27th 2012 ] - Market Wire
Oral Arguments in the UCSF Appeal of United State .. Judgment in Favor of InSite Vision Are Scheduled
[ Thu, Sep 27th 2012 ] - Market Wire
BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital
[ Thu, Sep 27th 2012 ] - Market Wire
Peregrine Pharmaceuticals Announces New Location of Annual Meeting of Stockholders
[ Thu, Sep 27th 2012 ] - Market Wire
A Refreshing Outlook - Consensus Reports on UnitedHealth Group Incorporated and Health Net Inc.
[ Thu, Sep 27th 2012 ] - Market Wire
FDA Clears Life Technologies' OpTmizera" T-Cell Growth Medium for Use in Clinical Trials
[ Thu, Sep 27th 2012 ] - Market Wire
Horizon Pharma to Present at the 11th Annual BIO Investor Forum
[ Thu, Sep 27th 2012 ] - Market Wire
AspenBio Plans to Initiate Pivotal Study in Fourth Quarter
[ Thu, Sep 27th 2012 ] - Market Wire
A Refreshing Outlook - Consensus Reports on Aetna Inc. and Coventry Health Care, Inc.
[ Thu, Sep 27th 2012 ] - Market Wire
Arnold C. Hanish Elected to Board of Directors of Omeros

Ceapro Announces Termination of Investor Relations Contract


//health-fitness.news-articles.net/content/2012/ .. -termination-of-investor-relations-contract.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


October 02, 2012 20:00 ET

Ceapro Announces Termination of Investor Relations Contract

EDMONTON, ALBERTA, CANADA--(Marketwire - Oct. 2, 2012) -Ceapro Inc. (TSX VENTURE:CZO) wishes to inform its shareholders that it has terminated its month to month contract with Renmark Financial Communications Inc. to provide investor relations services.

Questions regarding press releases can be forwarded to Branko Jankovic, the Chief Financial Officer.

About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides.

To learn more about Ceapro, visit [ www.ceapro.com ].

The TSX Venture Exchange nor its Regulation Services Provide (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.




Publication Contributing Sources